Protalix BioTherapeutics, Inc. (DE) (PLX): Price and Financial Metrics

PLX POWR Grades

• PLX scores best on the Value dimension, with a Value rank ahead of 85.46% of US stocks.
• The strongest trend for PLX is in Quality, which has been heading up over the past 47 days.
• PLX ranks lowest in Stability; there it ranks in the 15th percentile.

PLX Stock Summary

• PROTALIX BIOTHERAPEUTICS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 3.28% of US listed stocks.
• Of note is the ratio of PROTALIX BIOTHERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 12.53% of US stocks have a lower such ratio.
• PLX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 2.82% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to PROTALIX BIOTHERAPEUTICS INC are PULM, HYLN, SYBX, DBVT, and TCRX.
• Visit PLX's SEC page to see the company's official filings. To visit the company's web site, go to www.protalix.com.

PLX Valuation Summary

• PLX's price/earnings ratio is -4.5; this is 120.36% lower than that of the median Healthcare stock.
• Over the past 243 months, PLX's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for PLX.

PLX Growth Metrics

Its 2 year net cashflow from operations growth rate is now at 67.29%.
• Its 5 year net income to common stockholders growth rate is now at 88.31%.
• Its 4 year net cashflow from operations growth rate is now at 37.87%.

PLX's revenue has moved up $37,879,000 over the prior 49 months.

The table below shows PLX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	47.57	-27.476	-17.854
2022-06-30	45.441	-20.152	-18.486
2022-03-31	43.115	-6.28	-24.393
2021-12-31	38.35	-10.285	-27.582
2021-09-30	49.296	-12.748	-20.518
2021-06-30	48.032	-14.472	-20.756

PLX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PLX has a Quality Grade of C, ranking ahead of 73.31% of graded US stocks.
• PLX's asset turnover comes in at 0.547 -- ranking 71st of 681 Pharmaceutical Products stocks.
• MNKD, XTNT, and NBIX are the stocks whose asset turnover ratios are most correlated with PLX.

The table below shows PLX's key quality metrics over time.